Ghrelin signaling pathway in bronchial asthma
https://doi.org/10.18093/0869-0189-2016-26-1-92-97
Abstract
The aim of this article was to review a possible pathogenic role of ghrelin for bronchial asthma (BA). Ghrelin is a hormone participating in energy metabolism. Ghrelin takes part in embryonic lung growth and modulates inflammation and immunity. Ghrelin level is significantly decreased in patients with BA, especially in those with co-morbid obesity, and could decrease in BA patients after physical exercise. Ghrelin level is also significantly decreased during acute exacerbation of BA compared to stable BA. Ghrelin was shown to be inversely associated with bronchial hyperreactivity; therefore, ghrelin could play a protective role against bronchial hyperreactivity. Ghrelin inhibits synthesis of IgE directly or indirectly acting as a pathogenic link between obesity and allergy. Ghrelin inhibits expression of TNF-α, IL-6 и IL-1β, therefore, it should be considered as anti-inflammatory cytokine. In conclusion, ghrelin signaling pathway in BA was not studied completely. Further investigations could discover new approach to therapy of BA with this hormone including patients with BA and co-morbid obesity.
About the Authors
V. N. MineevRussian Federation
MD, Professor at M.V.Chernorutskiy Department of Hospital Internal Medicine, State Institution “Academician I.P.Pavlov First Saint-Petersburg State Medical University”, Healthcare Ministry of Russia; tel.: (812) 450-71-63
T. M. Lalaeva
Russian Federation
PhD, Doctoral candidate at M.V.Chernorutskiy Department of Hospital Internal Medicine, State Institution “Academician I.P.Pavlov First Saint-Petersburg State Medical University”, Healthcare Ministry of Russia; tel.: (812) 234-24-75
A. A. Lebedeva
Russian Federation
The 6th year student of Medical Faculty, State Institution “Academician I.P.Pavlov First Saint-Petersburg State Medical University”, Healthcare Ministry of Russia; tel.: (921) 338-23-08
References
1. Mineev V.N., Lalaeva T.M., Trofimov V.I. Bronchial asthma and obesity: common mechanisms. Klinicheskaja medicina. 2012; 4: 4–10 (in Russian).
2. Mineev V.N., Lalaeva T.M., Vasil'eva T.S. Leptin signaling pathways in bronchial asthma. Vestnik Sankt-Peterburgskogo universiteta. Ser. 11. 2013; 1: 34–44 (in Russian).
3. Mineev V.N., Lalaeva T.M., Vasil'eva T.S., Kuz'mina A.A. Adiponektin in soutum of patients with bronchial asthma. In: Collected scientific papers of the International Scientific and practical Conference «Actual problems of medicine». Volgograd; 2014: 106–111 (in Russian).
4. Mineev V.N., Lalaeva T.M., Vasil'eva T.S., Kuz'mina A.A. Clinical and pathogenic importance of resistin in patients with bronchial asthma and obesity. Uchenye zapiski SPbGMU im. akad. I.P.Pavlova. 2013; 20 (1): 31–35 (in Russian).
5. Mineev V.N., Lalaeva T.M., Kuz'mina A.A. A possible role of apelinergic system for pathogenesis of respiratory diseases. Pul'monologija. 2013; 2: 101–104 (in Russian).
6. Mineev V.N., Lalaeva T.M., Kuz'mina A.A. Blood apelin-12 in bronchial asthma. Kazanskij medicinskij zhurnal. 2014; 95 (5): 631–636 (in Russian).
7. Mineev V.N., Lalaeva T.M., Vasil'eva T.S., Kuz'mina A.A. rSTAT3 transcriptional factor expression in blood mononuclears and its leptin-induced modulation in bronchial asthma. Medicinskaja immunologija. 2014; 16 (6): 551–558 (in Russian).
8. Mineev V.N., Lalaeva T.M., Vasil'eva T.S., Kuz'mina A.A. Sputum as a source of adipokines in bronchial asthma. Scientific notes of PSPbGMU. 2014; 21 (3): 34–40 (in Russian).
9. Mineev V.N., Lalaeva T.M., Vasil'eva T.S., Kuz'mina A.A. Leptin in sputum of patients with bronchial asthma. Vestnik Sankt-Peterburgskogo universiteta. Ser. 11. 2014; 3: 50–55 (in Russian).
10. Santos M., Bastos P., Gonzaga S. et al. Ghrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofen-induced congenital diaphragmatic hernia. Pediatr. Res. 2006; 59 (4): 531–537.
11. Torday J.S., Sun H., Wang L. et al. Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 282: L405–L410.
12. Zhiharev S.S., Mineev V.N., Jablonskaja V.N. et al. Atopic bronchial asthma as pathology of membranes and receptors. Vestnik AMN SSSR. 1989; 2: 9–14 (in Russian).
13. Mineev V.N. Conception of bronchial asthma as pathology of membranes and receptors. Immunopatologija, allergologija, infektologija. 2005; 3: 68–85 (in Russian).
14. Baatar D., Patel K., Taub D.D. The effects of ghrelin on inflammation and the immune system. "Molecular and cellular endocrinology." Mol. Cell Endocrinol. 2011; "Go to table of contents for this volume/issue"340 (1): 44–58.
15. Volante M., Fulcheri E., Allмa E. et al. Ghrelin expression in fetal, infant, and adult human lung. J. Histochem. Cytochem. 2002; 50: 1013–1021.
16. Yuksel H., Sogut A., Yilmaz O. et al. Role of adipokines and hormones of obesity in childhood asthma. Allergy Asthma Immunol. Res. 2012; 4 (2): 98–103.
17. Matsuda K., Nishi Y., Okamatsu Y. et al. Ghrelin and leptin: a link between obesity and allergy? J. Allergy Clin. Immunol. 2006; 117: 705–706.
18. Cobanoglu N., Galip N., Dalkan C. et al. Leptin, ghrelin and calprotectin: inflammatory markers in childhood asthma? "Multidisciplinary respiratory medicine." Multidiscip. Respir. Med. 2013; 8 (1): 62.
19. Tsaroucha A., Daniil Z., Malli F. et al. Leptin, adiponectin, and ghrelin levels in female patients with asthma during stable and exacerbation periods. "The Journal of asthma : official journal of the Association for the Care of Asthma." J. Asthma. 2013; 50 (2): 188–197.
20. Javad A., Mohamadhosein G., Behnam M., Zohreh M. Serum ghrelin in response to acute exercise in adult men with mild to moderate asthma. Int. J. Biosci. 2014; 4 (4): 139–143.
21. Khoran H., Najafi G. Relationship between plasma ghrelin and immunoglobin E as allergic predictor in asthma patients. Eur. J. Exp. Bio. 2014; 4 (3): 500–504.
22. Matsumoto Y., Toyomasu K., Uchimura N., Ishitake T. Low-molecular-weight adiponectin is more closely associated with episodes of asthma than high-molecular-weight adiponectin. Endocr. J. 2013; 60 (1): 119–125.
23. Lee J.H., Lee B.H., Kim S.-H. Serum ghrelin level is associated with severity of bronchial hyperresponsiveness. Korean. J. Asthma Allergy Clin. Immunol. 2009; 29 (1): 46–52.
24. Itoh T., Nagaya N., Yoshikawa M. et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 170: 879–882.
25. Dixit V.D., Schaffer E.M., Pyle R.S. et al. Ghrelin inhibits leptin- and activation induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 2004; 114: 57–66.
26. Hattori N., Saito T., Yagyu T. et al. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 2001; 86: 4284–4291.
27. Sung E.Z., Da Silva N.F., Goodyear S.J. et al. Ghrelin promotes nuclear factor kappa-B activation in a human B-lymphocyte cell line. "Molecular biology reports." Mol. Biol. Rep. 2011; 38 (8): 4833–4838.
28. Haitov R.M. Immunology. A study book. Moscow: GJeOTAR-Media; 2013 (in Russian).
29. Mineev V.N., Nesterovich I.I., Trofimov V.I., Rybakova M.G. Apoptosis of target cells in bronchial asthma. Saint-Petersburg: Izdatel'stvovo «VVM»; 2014 (in Russian).
30. Mineev V.N., Trofimov V.I., Nesterovich I.I. et al. Blood lymphocyte apoptosis disorders in different phenotypes of bronchial asthma. Terapevticheskij arhiv. 2008; 3: 43–59 (in Russian).
31. Orlova E.G., Shirshev S.V. Regulation of membrane molecule expression and lymphocyte apoptosis by leptin and ghrelin in pregnancy. Problemy jendokrinologii. 2010; 3: 26–30 (in Russian).
32. Taub D.D., Murphy W.J., Longo D.L. Rejuvenation of the aging thymus: growth hormone- and ghrelin-mediated signaling pathways. Curr. Opin. Pharmacol. 2010; 10 (4): 408–424.
33. Li W.G., Gavrila D., Liu X. et al. Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells. Circulation. 2004; 109 (18): 2221–2226.
34. Liang Q.H., Liu Y., Wu S.S. et al. Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway. "Toxicology and applied pharmacology." Toxicol. Appl. Pharmacol. 2013; "Go to table of contents for this volume/issue"272 (3): 591–597.
35. Xu G., Li Y., An W., Zhang W. Ghrelin and cell differentiation Acta. Biochim. Biophys. Sin. 2008; 40 (10): 841–847.
36. Li B., Zeng M., He W. et al. Ghrelin protects alveolar macrophages against lipopolysaccharide-induced apoptosis through growth hormone secretagogue receptor 1a-dependent c-Jun N-terminal kinase and Wnt/β-catenin signaling and suppresses lung inflammation. "Endocrinology." Endocrinology. 2015; 1 (1): 203–217.
37. Tereshhenko I.V., Kajushev P.E. Ghrelin and its role in health and disease. Terapevticheskij arhiv. 2013; 4: 98–101 (in Russian).
Review
For citations:
Mineev V.N., Lalaeva T.M., Lebedeva A.A. Ghrelin signaling pathway in bronchial asthma. PULMONOLOGIYA. 2016;26(1):92-97. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-1-92-97